April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
April 15th 2025
Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.
April 14th 2025
The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.
April 10th 2025
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
April 9th 2025
Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.
Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study
February 19, 2016.
Translational Medicine: A “Team Sport”?
February 19, 2016
Asia-Pac Breast Cancer Market to Grow to $3.4 billion by 2021, Says Report
February 18, 2016.
Pharma Smackdown on Capitol Hill
Stakeholders React to England's Cancer Drug Fund Proposals
February 17, 2016.
Wyeth Agrees to $784 Million Medicaid Claim Fine
Vaccines Prove Effective and Cost-Effective
February 11, 2016.
Call for "Multi-Pronged Approach" to Fight Zika Virus
February 16, 2016.
FDA Warning to Cannabidiol Suppliers
February 15, 2016.
PhRMA Unveils New Ads Showing Patient Side of Biopharma Innovation
Little to Like in Obama’s Last Budget
February 12, 2016.
Industry and Patients: An Evolving Partnership
February 09, 2016.
Price to Avoid Vaccine Shortages, Say Researchers
Trial Results Boost Chances for BI Lung Cancer Drug Outside US
Congress to Keep a Close Watch on FDA
February 08, 2016
Negotiating Medicare Part D Prices
Can the feds negotiate Medicare Part D prices? Jill Wechsler reports.
Breakthrough Therapies Challenge FDA Reviewers, Manufacturers
The development of more complex biopharmaceutical therapies that merit accelerated evaluation and approval has put pressure on FDA to speed up its review process.
Sanofi Joins Fight Against Zika Virus
February 04, 2016.
Head and Neck Cancer Market "Will Quadruple" by 2024
Shkreli Braves the Storm
As Mr Shkreli goes to Washington, Casey McDonald considers what the silver screen treatment of this chapter in the pharma bro saga might be like.
Novartis Prepares for "Explosion" of Gleevec Copycats
February 03, 2016.
Sanofi Pasteur Launches Zika Vaccine Project
February 02, 2016.
Amgen "Clears First Regulatory Hurdle for Biosimilar Production"
4A's Partner Awards: Deadline for Entries Extended to February 12
French Bial Trial Death: Regulators Release Timeline of Events
February 01, 2016.
Harvard Business School Launches Precision Trials Challenge
28 January, 2016.
Final Rule on Covered Outpatient Drugs
January 29, 2016.
amFAR Awards $2 Million in AIDS Research Grants
January 28, 2016.
India’s Pharma Market to "Skyrocket to $55 Billion by 2020", Says Report
Roche Responds to Avastin Problem in India
January 27, 2016.